Studies were included if the medication was provided to patients with obesity or T2DM and if dietary intake was reported
Common digestive issues reported by semaglutide users include nausea, constipation, diarrhea, and general gastrointestinal discomfort
OCT angiography of acute non-arteritic anterior ischemic optic neuropathy
After a median follow-up of 7.9 years, the primary endpoint, 5-year disease-free survival, was 80.3% in the exercise group and 73.9% in the control group (difference, 6.4 percentage points
If youve tried diet and exercise and havent been able to lose excess weight or manage obesity, contact Michael Sutker, MD, in Dallas, Texas, today
You can depend on our weight loss clinic in Kentucky to deliver the exceptional care and expertise you need